Development and Function of B Cell Subsets

Molecular Biology of B Cells

Volumn , Issue , 2004, Pages 155-160

  Kearney, John F ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24744459748     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012053641-2/50011-3     Document Type: Chapter

References (76)

1. Amano, H., Amano, E., Moll, T., Marinkovic, D., Ibnou-Zekri, N. Martinez-Soria, E., Semac, I., Wirth, T., Nitschke, L., and Izui, S. The yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J Immunol 170, 2293-2301.
2. Ansel K.M., Harris R.B., Cyster J.G. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002, 16:67-76.
3. Arnold L.W., Pennell C.A., McCray S.K., Clarke S.H. Development of B1 cells: Segregation of phosphatidyl choline-specific B cells to the B1 population occurs after immunoglobulin gene expression. J Exp Med 1994, 179:1585-1595.
4. Balazs M., Martin F., Zhou T., Kearney J. Blood dendritic cells interact with splenic maginal zone B cells to initiate T-independent immune responses. Immunity 2002, 17:341-352.
5. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., MacKay F. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000, 192:1453-1465.
6. Baumgarth N., Herman O.C., Jager G.C., Brown L., Herzenberg L.A., Herzenberg L.A. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci USA 1999, 96:2250-2255.
7. Baumgarth N., Herman O.C., Jager G.C., Brown L.E., Herzenberg L.A., Chen J. B1 and B2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000, 192:271-280.
8. Bendelac A., Bonneville M., Kearney J.F. Autoreactivity by design: Innate B and T lymphocytes. Nat Rev Immunol 2001, 1:177-186.
9. Benedict C.L., Gilfillan S., Thai T.H., Kearney J.F. Terminal deoxynucleotidyl transferase and repertoire development. Immunol Rev 2000, 175:150-157.
10. Bendelac A., Rivera M.N., Park S.-H., Roark J.H. Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu Rev Immunol 1997, 15:535-562.
11. Boes M., Prodeus A.P., Schmidt T., M.C.Carroll, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998, 188:2381-2386.
12. Cariappa A., Pillai S. Antigen-dependent B-cell development. Curr Opin Immunol 2002, 14:241-249.
13. Cook G.A., Wilkinson D.A., Crossno J.T.J., Raghow R., Jennings L.K. The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin. Exp Cell Res 1999, 251:356-371.
14. Cyster J.G., et al. Chemokines and B-cell homing to follicles. Curr Top Microbiol Immunol 1999, 246:87-92.
15. Cyster J.G., Ansel K.M., Ngo V.N., Hargreaves D.C., Lu T.T. Traffice patterns of B cells and plasma cells. Adv Exp Med Biol 2002, 512:35-41.
16. Dighiero G., Borche L. Evidence that the B lymphocyte proliferating in B-CLL and in other B-cell malignancies is frequently committed to production of natural autoantibodies. Nouv Rev Fr Hematol 1990, 32:323-326.
17. Fagarasan S., Honjo T. T-independent immune response: New aspects of B cell biology. Science 2000, 290:9-92.
18. Fagarasan S., Watanabe N., Honjo T. Generation, expansion, migration and activation of mouse B1 cells. Immunol Rev 2000, 176:205-215.
19. Fredrickson T.N., Lennert K., Chattopadhyay S.K., Morse H.C., Hartley J.W. Splenic marginal zone lymphomas of mice. Am J Pathol 1999, 154:805-812.
20. Fukui Y., et al. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 2001, 412:826-831.
21. Garrone P., Neidhardt E., Garcia E., Galibert L., Kooten C., Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 1995, 182:1265-1273.
22. Girkontaite I., et al. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol 2001, 2:855-862.
23. Goodnow C.C. Balancing immunity, autoimmunity, and selftolerance. Ann N Y Acad Sci 1997, 815:55-66.
24. - B lymphocyte subsets. Eur J Immunol 1982, 12:564-569.
25. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000, 404:995-999.
26. Guinamard R., Okigaki M., Schlessinger J., Ravetch J.V. Abscence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 2000, 1:31-36.
27. Gunn M.D., et al. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998, 391:799-803.
28. Hargreaves D.C., Hyman P.L., Lu T.T., Ngo V.N., Bidgol A., Suzuki G., Zou Y.R., Littman D.R., Cyster J.G. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001, 194:45-56.
29. Hayakawa K., Asano M., Shinton S.A., Gui M., Allman D., Stewart C.L., Silver J., Hardy R.R. Positive selection of natural autoreactive B cells. Science 1999, 285:113-116.
30. Hirose S., Yan K., Abe M., Jiang Y., Hamano Y., Tsurui H., Shirai T. Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination. Proc Natl Acad Sci U S A 1997, 94:9291-9295.
31. Hu L., Rezanka L.J., Lustig A., Fischer R.T., Yoder J., Marshall S., Longo D.L., Kenny J.J. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J Immunol 2000, 15(164):4111-4119.
32. Jurgens J.G., Gartland L.A., Du Pasquier L., Horton J.D., Göbel T.W., Cooper M.D. Identification of a candidate CD5 homologue in the amphibian Xenopus laevis. J Immunol 1995, 155:4218-4223.
33. Kantor A.B., Stall A.M., Adams S., Herzenberg L.A. Adoptive transfer of murine B-cell lineages. Ann NY Acad Sci 1992, 651:168-169.
34. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., Hawkins N., Kelley M., Chang D., Van G., et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A 2000, 97:3370-3375.
35. Kipps T.J., Tomhave E., Chen P.P., Carson D.A. Autoantibody associated light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. J Exp Med 1998, 167:840-852.
36. Kipps T.J., Tomhave E., Pratt L.F., Chen P.P., Carson D.A. Developmentally restricted VH gene is expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1989, 86:5913-5917.
37. Knabel M., Cihak J., Lösch U. Characterization of new monoclonal antibodies identifying avian T lymphocyte antigens. Immunobiology 1993, 188:415-429.
38. Kuroda K., Han H., Tani S., Tanigaki K., Tun T., Furukawa T., Taniguchi Y., Kurooka H., Hamada Y., Tokyokuni S., Honjo T. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 2003, 18:301-312.
39. Lagresle C., Mondiere P., Bella C., Krammer P.H., Defrance T. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from Apo-1/Fasmediated apoptosis. J Exp Med 1996, 183:1377-1388.
40. Le Naour F., Rubinstein E., Jasmin C., Prenant M., Boucheix C. Severely reduced female fertility in CD9-deficient mice. Science 2000, 287:319-321.
41. Li Y., Li H., Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 2002, 195:181-188.
42. Lo C.G., Lu T.T., Cyster J.G. Integrin-dependence of lymphocyte entry into the splenic white pulp. J Exp Med 2003, 197:353-361.
43. Lu T.T., Cyster J.G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002, 297:409-412.
44. MacKay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710.
45. + B lymphocytes. Int Immunol 1990, 2:515-520.
46. Macpherson A.J., Gatto D., Sainsbury E., Harriman G.R., Hengartner H., Zinkernagel R.M. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000, 288:2222-2226.
47. Martin F., Kearney J.F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19 and btk. Immunity 2000, 12:39-49.
48. Martin F., Kearney J.F. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev 2000, 175:70-79.
49. Martin F., Kearney J.F. B1 cells: Similarities and differences with other B cell subsets. Curr Opin Immunol 2001, 13:195-201.
50. Martin F., Kearney J.F. Marginal-zone B cells. Nat Rev Immunol 2002, 2:323-335.
51. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001, 14:617-629.
52. Miyado K., Yamada G., Yamada S., Hasuwa H., Nakamura Y., Ryu F., Suzuki K., Kosai K., Inoue K., Ogura A., et al. Requirement of CD9 on the egg plasma membrane for fertilization. Science 2000, 287:321-324.
53. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., Zinkernagel R.M. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999, 286:2156-2159.
54. Ochsenbein A.F., Pinschewer D.D., Odermatt B., Carroll M.C., Hengartner H., Zinkernagel R.M. Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med 1999, 190:1165-1174.
55. Ochsenbein A.F., Pinschewer D.D., Odermatt B., Ciurea A., Hengartner H., Zinkernagel R.M. Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: Implications for splenectomized patients and vaccine design. J Immunol 2000, 164:6296-6302.
56. Ohdan H., Swenson K.G., Gray H.S.K., Yang Y.-G., Xu Y., Thall A.D., Tachibana I. Mac-1-negative B1b phenotype of natural antibody producing cells, including those responding to Galalpha 1,3 Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice. J Immunol 2000, 165:5518-5529.
57. Okamoto M., Murakami M., Shimizu A., Oxaki S., Tsubata T., Kumagai S., Honjo T. A transgenic model of autoimmune hemolytic anemia. J Exp Med 1992, 175:71-79.
58. Oliver A.M., Martin F., Gartland G.L., Carter R.H., Kearney J.F. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997, 27:2366-2374.
59. iE enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 1999, 162:7198-7207.
60. Osmond D.G., Rolink A., Melchers F. Murine B lymphopoiesis: Towards a unified model. Immunol Today 1998, 19:65-68.
61. + B cells predominate in peripheral tissues of rabbit. J Immunol 1992, 149:3858-3864.
62. Rathmell J., Townsend S.E., Xu J.C., Flavell R.A., Goodnow C.C. Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated the B cell antigen receptor. Cell 1996, 87:319-329.
63. Rolink A., Melchers F. B-cell development in the mouse. Immunol Lett 1996, 54:157-161.
64. Rothstein T.L., Wang J.K.M., Panka D.J., Foote L.C., Wang Z., Stanger B., Cui H., Ju S., Marshak-Rothstein A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995, 374:163-165.
65. Schattner E.J., Elkon K.B., Yoo D., Tumang J., Krammer P.H., Crow M.K., Friedman S.M. CD40-ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 1995, 182:1557-1565.
66. Smith K.G.C., Nossal G.J.V., Tarlinton D.M. Fas is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc Natl Acad Sci U S A 1995, 92:11628-11632.
67. Stall A.M., Well S.M., Lam K.P. B-1 cells: Unique origins and functions. Semin Immunol 1996, 8:45-59.
68. Su I.-H., Tarakhovsky A. B-cells: Orthodox or conformist?. Curr Opin Immunol 2000, 12:191-194.
69. Tachibana I., Hemler M.E. Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J Cell Biol 1999, 1999:893-904.
70. Tanigaki K., Han H., Yamamoto N., Tashiro K., Ikegawa M., Kuroda K., Suziki A., Nakano T., Honjo T. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immunol 2002, 3:443-450.
71. Tanigaki K., Kuroda K., Han H., Honjo T. Regulation of B cell development by Notch/RBP-J signaling. Semin Immunol 2003, 15:113-119.
72. Wang J., Taniuchi I., Maekawa Y., Howard M., Cooper M.D., Watanabe T. Expression and function of Fas antigen on activated murine B cells. Eur J Immunol 1996, 26:92-96.
73. Watanabe N., Ikuta K., Fagarasan S., Honjo T., Tchiba T. Migration and differentiation of autoreactive B1 cells induced by activated T cells in antierythrocyte immunoglobulin transgenic mice. J Exp Med 2000, 192:1577-1586.
74. Wither J.E., Roy V., Brennan L.A. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZBXNZW)F1 mice. Clin Immunol 2000, 94:51-63.
75. Won W.J., Masuda K., Kearney J.F. CD9 is a novel marker that discriminates between marginal zone and follicular B cells [abstract]. FASEB J 2000, 14:A1191.
76. Zeng D., Lee M.-K., Tung J., Brendolan A., Strober S. A role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol 2000, 164:5000-5004.